Ibex Investors LLC Vista Gen Therapeutics, Inc. Transaction History

Ibex Investors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 07, 2019	SELL	$1.1 - $1.76 $198,000 - $316,800	-180,000 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$1.23 - $1.49 $12,300 - $14,900	-10,000 Reduced 5.26%	180,000 $261,000
Q2 2018 Aug 14, 2018	BUY	$0.85 - $1.5 $8,500 - $15,000	10,000 Added 5.56%	190,000 $260,000
Q1 2018 May 15, 2018	BUY	$0.91 - $1.73 $163,800 - $311,400	180,000 New	180,000 $167,000

2.7M

Ticker VTGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 206,836,000
Market Cap $730M
Description
VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III d...

Get notified when there are updates to the investment portfolio of Ibex Investors LLC, based on Form 13F filings with the SEC.

Stay updated on Ibex Investors LLC with notifications on news.